Can Patents Ever Be “Ever-Greened”? The Answer…They Are “Never-Greened” 20/05/2016 by Intellectual Property Watch 9 Comments “Ever-Greening of Patents” has been an expression that has been extensively used in debates related to the global pharmaceutical industry at least since the last two decades. Interestingly, this term has never been statutorily defined and hence has been applied most freely by professionals, policy makers and politicians alike. It would be appropriate to objectively examine whether patents in any jurisdiction can ever be “ever-greened”. A fitting initiation to this debate is the very concept of what a patent is from the very first principles, writes Prabuddha Ganguli.
Document Explains Decision Granting Sovaldi Patent To Gilead 10/05/2016 by Patralekha Chatterjee for Intellectual Property Watch Leave a Comment A copy of the new Indian patent office order shows the details of the decision to reverse an earlier direction and grant a patent in India on the high-value hepatitis C drug. [Updated with response from Gilead]
Surprise! Much Work Being Done On Transparency Of Patents On Medicines 28/04/2016 by Intellectual Property Watch Leave a Comment James Love writes: In a recent paper by Reed F. Beall and Amir Attaran [KEI’s April 12, 2016 comment here: http://www.keionline.org/node/2467], and in the WIPO seminar discussions about the paper, the authors have held themselves out as more or less lonely voices calling for transparency of patent landscapes on essential medicines. This surprised and offended the many people who have not only been concerned about the lack of transparency on patent landscapes, but have been doing most of the work in digging out the facts, and/or proposing remedies.
Failsafe Tips For Identifying And Developing Potentially Valuable Patents 20/04/2016 by Intellectual Property Watch 2 Comments It’s easy to find valuable and useful patents, if you have small patent portfolios, but it can be a daunting task when portfolios contain hundreds or thousands of patents. Yet this task is critical for any business, and especially for technology companies that typically hold significant portfolios.
Russia: New Amendments Would Allow Use Of Inventions Without Permission Of Patent Holders 18/04/2016 by Eugene Gerden for Intellectual Property Watch 1 Comment The Russian government is considering approval of a package of controversial amendments to national legislation that would allow the use of inventions without the permission of patent holders.
IP Valuation For Universities, Patent Flexibilities On Tap At WIPO 07/04/2016 by Catherine Saez, Intellectual Property Watch 1 Comment The World Intellectual Property Organization Committee on Development and Intellectual Property (CDIP) meets next week with a focus on how universities and research institutions can best derive value from their discoveries. Also on the agenda are proposed projects and several documents mapping WIPO development-related activities, such as South-South cooperation. And the action kicks off this week with a wide-ranging conference on IP and development at WIPO.
GSK Eases IP Rights For Poorest Countries, Considers Patent Pooling For Cancer 31/03/2016 by Catherine Saez, Intellectual Property Watch 2 Comments In light of the United Nations Secretary General’s High-Level Panel on Access to Medicines initiative, the GlaxoSmithKline company today announced steps to further help bring innovative medicines to poor countries.
Despite Supreme Court Ruling, Foreign Sales Don’t Affect US Patent Rights 29/03/2016 by Steven Seidenberg for Intellectual Property Watch Leave a Comment The controversial ruling was perhaps to be expected. The Federal Circuit Court of Appeals doggedly hewed to its existing interpretation of patent law. Unfortunately, the court’s decision in Lexmark International v Impression Products conflicts with recent Supreme Court jurisprudence, according to many experts – thus leaving unresolved some important questions about how much control patentees can maintain over their patented products.
Asia On The Heels Of US And Europe In Patent Applications At WIPO; Developing Countries Lagging 16/03/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment China, Japan and South Korea are among the top five countries filing international patent applications at the World Intellectual Property Organization, while the United States continues to lead in patent and trademark applications. Far behind, developing countries seem to be having a hard time catching up.
MSF Challenges Pfizer Patent Application For Pneumonia Vaccine In India 11/03/2016 by Intellectual Property Watch 1 Comment Today, Médecins Sans Frontières (MSF, Doctors Without Borders) filed a patent opposition against Pfizer’s vaccine for pneumonia in India.